Jon Bates - Mar 1, 2025 Form 4 Insider Report for Nutex Health, Inc. (NUTX)

Role
Chief Financial Officer
Signature
/s/ Jon Bates
Stock symbol
NUTX
Transactions as of
Mar 1, 2025
Transactions value $
$81,810
Form type
4
Date filed
4/14/2025, 04:30 PM
Previous filing
Aug 26, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUTX Common Stock Options Exercise $0 +111 +4.87% $0.00 2.39K Mar 1, 2025 Direct F1
transaction NUTX Common Stock Options Exercise $0 +1.5K +62.81% $0.00 3.89K Mar 1, 2025 Direct F1
transaction NUTX Common Stock Purchase $81.8K +1K +25.72% $81.81 4.89K Apr 8, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUTX Restricted Stock Units Options Exercise $0 +3.5K +116.67% $0.00 6.5K Mar 10, 2025 Common Stock 3.5K $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On March 10, 2025, the Reporting Person was granted 3,500 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.